Severe Eosinophilic Asthma

DrugDrug NameDrug Description
DB12023BenralizumabA monoclonal antibody used to treat eosinophilic asthma.
DB06612MepolizumabAn IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults.
DB06602ReslizumabAn IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults.
DrugDrug NamePhaseStatusCount
DB11900OC-4592Completed1
DB12023Benralizumab4Not Yet Recruiting2
DB01222Budesonide4Not Yet Recruiting1
DB00983Formoterol4Not Yet Recruiting1
DB01001Salbutamol4Not Yet Recruiting1
DB06612MepolizumabNot AvailableRecruiting1